Deciphera Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-2.293; its P/E ratio is -6.40; Deciphera Pharmaceuticals is scheduled to report earnings on May 1, 2024, and the estimated EPS forecast is $-0.55. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 48.29M	$ 43.31M	$ 37.32M	$ 33.22M	$ 36.34M
Gross Profit	$ 46.51M	$ 42.03M	$ 38.13M	$ 33.93M	$ 33.10M
EBIT	-	$ -60.74M	$ -61.42M	$ 136.31M	$ -5.58M
EBITDA	-	$ -61.18M	$ -61.69M	$ 136.45M	-
Net Income Common Stockholders	$ -47.19M	$ -60.74M	$ -48.56M	$ 136.31M	$ -6.31M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 306.22M	$ 339.07M	$ 328.74M	$ 398.63M	$ 324.49M
Total Assets	$ 473.57M	$ 497.84M	$ 509.62M	$ 549.02M	$ 454.04M
Total Debt	$ 25.88M	$ 26.71M	$ 27.52M	$ 28.32M	$ 29.11M
Net Debt	$ -280.34M	$ -312.37M	$ -301.22M	$ -370.31M	$ -295.37M
Total Liabilities	$ 122.65M	$ 116.17M	$ 105.19M	$ 108.94M	$ 487.40M
Stockholders Equity	$ 350.92M	$ 381.67M	$ 404.43M	$ 440.08M	$ 375.05M
Cash Flow	-
Free Cash Flow	-	$ -29.84M	$ -39.75M	$ -49.02M	$ -35.18M
Operating Cash Flow	$ -28.81M	$ -29.78M	$ -39.45M	$ -48.66M	$ -35.20M
Investing Cash Flow	$ 2.20M	$ 41.40M	$ 4.36M	$ -35.41M	$ 16.30M
Financing Cash Flow	$ 890.00K	$ 15.59M	$ 838.00K	$ 134.69M	$ 478.00K

Currency in USD

Deciphera Pharmaceuticals Earnings and Revenue History

Income Statement >

Deciphera Pharmaceuticals Debt to Assets

Balance Sheet >

Deciphera Pharmaceuticals Cash Flow

Cash Flow >

Deciphera Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing